Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P
As of early 2026, no peer-reviewed human clinical trials for TB-500 specifically have been published
Vieta E, Valent M
How doctors of optometry can help While GLP-1RAs can significantly improve cardiovascular and diabetes symptoms, patients with preexisting ocular disease might be at increased risk
In experimental wound healing models, TB-500 treatment increases capillary density by 40-50% while improving functional blood flow restoration, demonstrating translation of cellular angiogenic activity into meaningful tissue-level perfusion benefits
US$ 25.27
US$ 28.18
US$ 21.51
US$ 28.08
US$ 22.19
US$ 28.81
